Not Signed In - Watson Announces Positive Phase 3 Study Results On Silodosin For Treatment Of Benign Prostatic Hyperplasia
Wed, 17 Jan 2007 08:00 AM EST
... Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced positive top-line data from two Phase 3 studies of silodosin, the Company's investigational drug being studied for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH). [click link for full article] ...
Related Topics
- Benign Prostatic Hyperplasia
- Prostate Diseases
- BPH Benign Prostatic Hyperplasia
- Enlarged Prostate/Benign Prostatic Hyperplasia
- Prostate Enlargement: Benign Prostatic Hyperplasia
- BPH
- Benign Tumors
- Benign Tumor
- Tb
- Tremor
- Dizziness and Vertigo
- Hypotonia
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Brain injury that results in physical, emotional, or intellectual changes or deficits
- Hyperplasia
- Urinalysis
- Treatment
- Gingival Hyperplasia
- Parathyroid hyperplasia
email this page
print this page
bookmark this page
feedback on this page
